Background: The impact of age as a prognostic factor for patients with colorectal cancer (CRC) remains controversial, possibly due to heterogeneity between studies in terms of patient numbers, percentage of patients undergoing curative resection, percentage of patients receiving neoadjuvant therapy, or failure to adjust for potential confounding factors. This study used colorectal cancer survival data from the Taiwan Cancer Registry database in order to comprehensively analyze age as a prognostic factor. Methods: Survival data were analyzed for 62 060 CRC patients diagnosed with adenocarcinoma, mucinous adenocarcinoma, or signet-ring cell carcinoma of the colon and rectum between 1998 and 2005. The rates of all-cause mortality and CRC-related mortality were determined using Kaplan-Meier analysis, and the log-rank test was used to compare differences in survival between different age groups. The crude and adjusted hazard ratios for all-cause and CRC-related mortalities were calculated according to the estimates from the univariable and multivariable Cox proportional hazard models. Results: Patients in the ≤40 and the 41-50 age groups had a higher proportion of mucinous adenocarcinoma (P < 0.001) and signet-ring cell carcinoma (P < 0.001) compared to the older age groups. After adjusting for gender, histology, and tumor site, patients in the ≤40 age group had a poorer overall survival (OS) and cancer-specific survival compared to patients in the 41-50 and 51-60, and 61-70 age groups (P < 0.001), but a better OS and cancer-specific survival compared to patients in the 71-80 and >80 age groups (P < 0.001). Conclusions: Our study indicated that age is an important consideration while determining the clinical management of CRC patients.
Introduction
Despite recent progress in imaging techniques, surgical interventions, and systemic therapy, there has been a steady increase in the incidence of colorectal cancer (CRC) in Asia (1, 2) . More than 90% of CRC patients are diagnosed in their 50s-70s (3), although as many as 7% of patients who develop CRC are under 40 years of age at the time of diagnosis (4, 5) . A number of studies have reported that patients aged 20-40 years old constitute between 1.6% and 23% of all CRC cases in China (4, (6) (7) (8) . The incidence of CRC among older adults has remained stable, while the incidence among adults aged 20-40 years old has steadily increased (4) . Treatment strategies for young as well as old CRC patients consist of CRC staging followed by segmental colectomy, adjuvant chemotherapy, and routine surveillance colonoscopies every year (9) .
Studies investigating the clinical features and prognosis of CRC showed that compared to older patients, younger patients had a higher prevalence of mucinous or poorly differentiated tumors, including signet ring tumors, which tend to have a poorer prognosis compared to well-and moderately differentiated tumors (10, 11) . However, while some studies reported that younger patients had a more advanced stage of disease at the time of diagnosis (4, (12) (13) (14) (15) , more aggressive histopathologic characteristics (16) (17) (18) (19) (20) , and poorer prognosis compared to older patients (10, (21) (22) (23) , data from other studies contradicted these findings (24) (25) (26) (27) (28) . Interestingly, it was recently reported that the poor prognosis of patients <35 years old was primarily due to their advanced stage tumors; however, after excluding the impact of tumor stage, age was not an independent prognostic factor (29) .These conflicting data could be due to factors such as heterogeneity between the different studies in terms of patient numbers, percentage of patients undergoing curative resection, percentage of patients receiving neoadjuvant therapy, and failure to adjust for potential confounding factors.
We previously investigated the impact of gender on prognosis of CRC and showed that female CRC patients aged between 50 and 80 years old had a better OS compared to males. Our results suggested that, in addition to gender, age could also be an important factor impacting the prognosis of CRC (30) . These data, along with findings showing an increasing incidence of CRC among young adults (<40 years old), make it very important to understand the etiological as well as prognostic factors in this patient population. The present study is a large-scale cohort study which aimed to analyze whether age represents a prognostic factor in CRC.
Methods

Data acquisition and study population
This retrospective cohort study enrolled a total of 65 113 CRC patients from the Taiwan Cancer Registry, a population-based cancer registry which has recorded all newly diagnosed malignant neoplasms in Taiwan since 1979. Our study included all cases in the Registry with histology codes consistent with adenocarcinoma, mucinous adenocarcinoma, or signet-ring cell carcinoma of the colon and rectum, and used ICD-9 codes 153.0, 153. . This study cohort was the same cohort of patients described in our previous study (30) , and included all deaths reported up to the end of 2008. The major exclusion criteria for this study were histology codes consistent with squamous-cell carcinoma (n = 317), gastrointestinal stromal sarcoma (n = 103), carcinoid tumor (n = 347), malignant melanoma (n = 69), sarcoma (n = 124), lymphoma (n = 244) or other unspecified malignancies (n = 101). As described in our previous study, patient information extracted from the registry included the patient's date of birth, date of diagnosis, age, gender, diagnostic methods, cancer sites, histology, grade of differentiation and date of death (30) . Information from the Registrar General was used to validate the date and cause of death collected from the Registry. Patients with tumors occurring from the cecum to the sigmoid colon were classified as the colon group, while patients with tumors of the rectosigmoid junction and rectum were classified as the rectal group.
Data for this study were sourced from Taiwan's National Health Insurance (NHI), and the cancer registry database, which are both linked to the residential administration agency. Since the cancer database is linked with the residential administration agency, a patient who dies is removed from the residential registry by the residential administration agency, and the cancer registry records the death when it compiles statistics for the current year. As a consequence, data on CRC-related deaths were available to us through the residential administration agency's registry removal and cause of death records. No patients were lost to follow-up as a result of this linkage between the NHI, the cancer database and the residential administration agency.
This study was approved by the Institute of Review Board of Chi-Mei Medical Center.
Statistical analysis
All statistical analyses were performed using SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA). Age was presented as mean and standard deviation in the male and female groups, and compared using the independent two samples t-test. Categorical data were presented as number with percentage, and tested with the Fisher's exact test. Survival analyses were performed using all-cause mortality and CRC-related mortality. The corresponding survival times for allcause mortality and CRC-related mortality were calculated from the date of diagnosis to the date of mortality. The event of all-cause mortality was defined as patients with any death during the study period, and the CRC-related mortality was defined as patients died due to CRC during the study period. The rates of all-cause mortality and CRC-related mortality were determined using Kaplan-Meier analysis, and the log-rank test was used to compare differences between survival curves. The crude and adjusted hazard ratios for all-cause and CRC-related mortalities were calculated according to the estimates from the univariable and multivariable Cox proportional hazard models. The level of statistical significance was set at P < 0.05. All reported P values are two-tailed.
Results
Patient demographics and clinical characteristics
Of the 65 113 patients that registered from 1998 to 2005, 63 365 had a definite diagnosis of malignant cancer (Fig. 1 ). Of these, 1 576 were excluded for having squamous cell carcinoma, gastrointestinal stromal sarcoma, carcinoid tumor, malignant melanoma, sarcoma, lymphoma, other unspecified malignancies and appendix carcinoma. The final population included 61 789 patients of which 35 316 (57.2%) were males and 26 473 (42.8%) were female (30) .
Analysis of patient demographics and clinical characteristics showed that patients ≤40 years old comprised~5.5% of our study population, and the mean age of the CRC patients was 64.9 years (SD = 13.6). Analysis of pathological characteristics showed a statistically significant difference in gender, histology, and cancer site distribution between the various age groups (Supplementary Table 1 ). The two younger age groups (≤40 years and 41-50 years) had significantly higher proportions of mucinous adenocarcinoma and signet-ring cell carcinoma than the older age groups.
All-cause mortality and CRC mortality
During the study period, there were 33 549 all-cause deaths and 28 249 CRC-related deaths (Supplementary Table 2 ). The 1-year, 3-year and 5-year rates of all-cause mortality were 20.6%, 40.6% and 50.5%. The 1-year, 3-year and 5-year rates of CRC-related mortality were 18.5%, 36.7% and 45.3% (data not shown).
Association of age with all-cause mortality
Patients in the two highest age groups (>80 and 71-80 years) had significantly higher rates of all-cause mortality compared to patients in the younger age groups. However, patients who were 40 years or younger had (1) significantly higher rates of all-cause mortality compared to the age groups 41-50 and 51-60 (both P < 0.001), and (2) comparable rates of all-cause mortality with the 61-70 age group (P = 0.889). In addition, patients in the 41-50 years age group had significantly higher rates of all-cause mortality compared to the 51-60 age group (P = 0.007) (Fig. 2) .
The hazard ratios for all-cause mortality after adjusting for gender, histology and site of tumor are summarized in Table 1 . Based on the crude as well as adjusted hazard ratios, patients in the 41-50 and the 51-60 age groups had a lower risk of all-cause mortality than patients in the ≦40 age group (P < 0.001, respectively). However, patients in the 71-80 and >80 age groups had a significantly higher risk of all-cause mortality than patients in the ≦40 age group (P < 0.001, respectively).
Association of age with CRC-related mortality
Patients in the two highest age groups (>80 and 71-80 years) had significantly higher rates of CRC-related mortality compared to patients in the younger age groups. However, patients in the ≦40 age group had significantly higher rates of CRC-related mortality compared to the 41-50, 51-60 and 61-70 age groups (P < 0.001). The rates of CRC-related mortality were comparable in patients from the 41-50 and the 61-70 age groups. However, patients in the 41-50 age group had significantly higher rates of CRC-related mortality compared to patients in the 51-60 age group (P < 0.001) (Fig. 3) .
The crude and adjusted HRs showed that patients in the 41-50, 51-60 and 61-70 age groups had a significantly lower risk of CRCrelated mortality compared to patients in the ≦40 age group (P < 0.001, respectively). However, patients in the 71-80 and >80 age groups had a significantly higher risk of CRC-related mortality compared to patients in the ≦40 age group (P < 0.001, respectively) ( Table 1) .
Association of age and all-cause mortality stratified by histology
Since patients with mucinous adenocarcinoma and signet-ring cell carcinoma had a significantly higher risk of all-cause mortality than patients with adenocarcinoma (data not shown), we stratified the association of age and all-cause mortality by histology.
In patients with adenocarcinoma, there was a lower risk of allcause mortality in patients from the 41-50 and 51-60 age groups compared to patients in the ≦40 age group (crude HRs of 0.90 and 0.86, P = 0.002 and P < 0.001, respectively; adjusted HRs of 0.91 and 0.85, P = 0.003 and P < 0.001, respectively). Patients in the 71-80 and >80 age groups had a higher risk of all-cause mortality compared to patients in the ≦40 age group (P < 0.001, respectively) ( Table 2) . Kaplan-Meier analysis showed significantly higher mortality rates in the 41-50 age group compared to the 51-60 age group (P = 0.017), and patients in the 71-80 and >80 age groups Kaplan-Meier estimates for all-cause mortality rates in different age groups. *indicates that the corresponding age group had a significantly higher mortality rate than all the other younger age groups.
† indicates that the mortality rates of the two groups (≤40 and 61-70 years) were comparable, and significantly higher than the 41-50 and 51-60 age groups. ‡
indicates that the 41-50 age group had a significantly higher mortality rate than the 51-60 age group.
had significantly higher mortality rates compared to the younger groups (all P values < 0.001) (Fig. 4A) .
In patients with mucinous adenocarcinoma, there was a significantly lower risk of all-cause mortality in patients from the 41-50 age group compared to patients in the ≦40 age group (crude HRs of 0.77, P = 0.018; adjusted HRs of 0.76, P = 0.015). Patients in the >80 age group had a significantly higher risk of all-cause mortality compared to patients in the ≦40 age group (all P < 0.001) ( Table 2) . Kaplan-Meier estimates showed that patients in the >80 age group had significantly higher mortality rates compared to all the younger age groups (P values < 0.001) (Fig. 4B) .
In patients with signet-ring cell carcinoma, there was a significantly lower risk of all-cause mortality in patients from the 51-60 age group compared to patients in the ≦40 years age group (crude HRs of 0.59, P = 0.023; adjusted HRs of 0.57, P = 0.016) ( Table 2) . Kaplan-Meier analysis showed a significantly lower mortality rate in the 51-60 age group compared to all the other groups (Fig. 4C) .
Associations of age and CRC-related mortality stratified by histology
Since patients with mucinous adenocarcinoma and signet-ring cell carcinoma had a significantly higher risk of CRC-related mortality compared to those with adenocarcinoma (data not shown), we further stratified the associations of age and CRC-related mortality by histology.
In patients with adenocarcinoma, both crude and adjusted hazard ratios showed that patients in the 41-50, 51-60 and 61-70 age groups had a significantly lower risk of CRC-related mortality compared to patients in the ≦40 age group (all P values < 0.001). However, patients in the 71-80, and the >80 age groups had a significantly higher risk of CRC-related mortality compared to patients in the ≦40 age group (all P < 0.001) ( Table 2) . Kaplan-Meier estimates showed a significantly higher CRC-related mortality rate in patients from the 71-80 and the >80 age groups compared to all the younger age groups (P values < 0.001) (Fig. 5A) .
In patients with mucinous adenocarcinoma, there was a lower risk of CRC-related mortality in patients from the 41-50 and the 51-60 age groups compared to patients from the ≦40 age group (crude HRs of 0.78 and 0.78, respectively; P = 0.026 and P = 0.026; adjusted HRs of 0.77 and 0.78, respectively; P = 0.020 and P = 0.022). However, patients in the >80 age group had a higher risk of CRC-related mortality compared to patients in the ≦40 age group (both P < 0.001) ( Table 2) . Kaplan-Meier estimates showed that the ≦40 age group had a significantly higher CRC-related mortality rate compared to patients in the 41-50 and the 51-60 age groups (P values = 0.022 and 0.021, respectively), while patients in the >80 age group had significantly higher CRC-related mortality rates compared to all the other younger groups (P values < 0.001) (Fig. 5B) .
In patients with signet-ring cell carcinoma, patients in the 51-60 age group had a lower risk of CRC-related mortality in patients from the 51-60 age group compared to patients in the ≦40 age group (P = 0.008 and P = 0.005, respectively) ( Table 2) . KaplanMeier estimates showed that patients in the 51-60 age group had significantly lower CRC-related mortality rates compared to all the other five groups (Fig. 5C ).
Discussion
In this retrospective study of 62 060 CRC patients, we showed a significant correlation between age and all-cause as well as CRCrelated mortality. CRC patients in the ≦40 age group had a higher risk of all-cause mortality and CRC-related mortality compared to the 41-50 and the 51-60 age groups, although the risk was lower compared to the 71-80 and >80 age groups. Patients in the ≦40 age group also had more aggressive histopathologic characteristics, and Adjusted by gender, histology and site. Figure 3 . Kaplan-Meier estimates for CRC mortality rates in different age groups. *indicates that the corresponding age group had a significantly higher CRC mortality rate than all the other younger age groups. † indicates that the patients in the ≤40 age group had a significantly higher CRC mortality rate than those in the 41-50, 51-60 and 61-70 age groups. ‡ indicates that the CRC mortality rates of the 41-50 and 61-70 age groups were comparable, and significantly higher than the 51-60 age group.
poorer overall survival (OS) as well as cancer-specific survival compared to patients in the 41-50 and the 51-60 age groups, although this trend was reversed in the 71-80 and >80 age groups.
Age has been shown to be a significant, but complex prognostic factor for CRC. Older CRC patients (>70 years old) who tend to have well-differentiated, right-sided tumors, typically have a higher rate of non-cancer-related deaths compared to younger patients (31), while younger patients had significantly lower rates of OS possibly because they are diagnosed at a late stage, and have poorly differentiated, more aggressive tumors (32, 33) . Consistent with this, CRC patients aged 20-40 years old have been shown to have a higher incidence of mucinous, and signet cell tumors, and a higher percentage of poorly differentiated and anaplastic tumors compared to patients aged 60-80 (8, 12, 18, 26, 34) .
In contrast, other studies reported (1) better prognosis in younger patients (<45 years old) compared to older patients despite the higher incidence of locally advanced tumors in younger patients (35, 36) , or (2) no significant difference in overall survival between younger and older patients (12, 37) . Some of these discrepancies may reflect the fact that these were institutional retrospective reviews and included selection biases.
In the present study, we investigated whether age had an impact on the prognosis of CRC. We classified patients into 40, 41-50, 51-60, 61-70, 71-80 and >80 age groups. Since our study population included only Taiwanese, who comprise a single ethnic population, we ruled out the role of ethnicity on the effects observed in this study. Our data showed that patients in the ≦40 age group had poorer rates of 1-, 3-and 5-year OS and poorer cancer-specific survival compared to patients in the 41-50 and the 51-60 age groups. We also found that younger CRC patients had more aggressive histopathologic characteristics compared to patients in the 41-50 and the 51-60 age groups, which may be reflected in the poor prognosis in this group of patients. However, after adjusting for gender, histology, and site of tumor, patients in the ≦40 age group had significantly lower rates of all-cause and CRC-related mortality compared to patients in the 71-80 and the >80 age groups. Although we found a significantly higher percentage of mucinous adenocarcinomas and signet-ring cell carcinomas in the ≦40 and the 41-50 age groups compared to the older age groups, these percentages were lower (7.71% for mucinous adenocarcinoma and 2.43% for signet-ring carcinoma) compared to previous retrospective Western studies from tertiary centers which may have had selection biases (5,9). The higher percentage of patients in the ≦40 with mucinous adenocarcinomas and signet-ring cell carcinomas, which have worse prognosis than adenocarcinoma, and may in part, underlie the poorer prognosis of this age groups. The poorer prognosis may also reflect the fact that CRC is considered a disease of older patients and that younger patients are not commonly screened for the disease via a colonoscopy. Hence, the disease is often advanced at diagnosis in younger patients compared with the older age groups. Other important prognostic factors, such as TNM stage and residual tumor following surgery could not be evaluated as this information is not included in the NHI database. Although, this type of information can be gathered by clinical trials or clinicspecific registries, the population in these studies is typically not large enough to be able to evaluate the impact of age on prognosis in CRC patients.
The small sample sizes of previous studies may call into question the power of the studies and hence, the interpretation of the findings. Since our present study included all patients from the NHI database of Taiwan, our sample size was large and selection bias should not be a problem. It is also important to note that our present study utilized data from Taiwan's NHI system which covers 99% of the residents in Taiwan, and has contracts with 97% of the medical providers there. Due to the unique NHI system providing universal coverage and guaranteed equal access to health care services, the Taiwan Cancer Registry captures nearly all newly diagnosed cancers in Taiwan each year. Although this study did not evaluate any other potential survival-related factors other than age, it is reasonable to assume that the major causes of mortality in the ≦40 age group would be cancer and accidents, whereas the older age groups would have a higher percentage of mortality caused by co-morbidities. Young age at the onset of CRC has been shown to be associated with inherited CRC syndromes such as MUTYH-associated polyposis, familial adenomatous polyposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC or Lynch syndrome) and inflammatory bowel disease, suggesting that age of CRC onset is an important indicator of familial history and/or genetic predisposition (9, 38) . Approximately 2-5% of all CRCs are associated with Lynch syndrome, which is characterized by excessive synchronous and metachronous CRCs, and presence of tumor-infiltrating lymphocytes, signet ring cells, or a strong mucinous component (39, 40) . Although the incidence of Lynch syndrome in Taiwan during the study period has been reported to be 2.3% (41) , there are no studies reporting the incidence of FAP or inflammatory bowel disease during this period. Patients with Lynch syndrome were not excluded from our study, and this was an important limitation of the present study. However, it is important to note that even with the inclusion of patients with Lynch syndrome patients, our data showed that the prognosis was still significantly poorer in younger patients compared to older patients. Exclusion of patients with Lynch syndrome would have resulted in an even worse prognosis in the younger age group.
Our study had some additional limitations. Due to the implementation of the Personal Information Protection Act, our registry did not include data for TNM stage, or presence of a residual tumor following surgery with curative intent (the R classification of the AJCC/UICC staging system), which are the most important prognostic factors in CRC (42) . In addition, the registry did not include information regarding surgical treatment, postoperative condition, or postoperative recurrence rate. These factors were therefore not Figure 4 . Kaplan-Meier estimates for all-cause mortality rates in different age groups by histology. (A) Adenocarcinoma group. *indicates that the corresponding age group had a significantly higher mortality rate than all the other younger age groups.
† indicates that the mortality rates of the ≤40 and 61-70 age groups were comparable, and significantly higher than the 41-50 and 51-60 age groups. ‡ indicates that the 41-50 age group had a significantly higher mortality rate than the 51-60 age group. (B) Mucinous adenocarcinoma group. *indicates that the corresponding age group had a significantly higher mortality rate than all the other younger age groups.
† indicates that the mortality rates of the ≤40, 61-70 and 71-80 years were comparable, and were significantly higher than the 41-50 and 51-60 age groups. ‡ indicates that the 41-50 and 51-60 age groups had comparable mortality rates. (C) Signet-ring cell carcinoma group. ‡ indicates that the 51-60 age group had a significantly lower mortality rate than all the other five groups.
included in our Cox regression model. Although natural mortality rates influence survival in older age groups, an analysis of relative survival would require a merge of the country's life table. However, we did not have enough information to perform this analysis, and this is another limitation of this study. Additionally, it is possible that the differential classification of the cause of death on death certificates may be a potential confounder, based on potential inaccuracies in categorization of cause of death (43) .
Conclusions
In this population-based study, we showed that age affected the rate of overall survival in CRC patients. To the best of our knowledge, we are the first to report that after adjusting for gender, histology and site of tumor, CRC patients in the ≦40 age group had more aggressive histopathologic characteristics, and poorer OS as well as cancer-specific survival compared to patients in the 41-50 and the 51-60 age groups. However, CRC patients >70 years old had a poorer prognosis compared to patients in all the younger age groups.
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